Starling Oncology, Inc. Interest Payable, Current
Starling Oncology, Inc. (DFPH) had Interest Payable, Current of $868.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2026-08-06
- 2026-06-30: Interest Payable, Current $868.00K.
- 2026-03-31: Interest Payable, Current $849.00K.
- 2025-12-31: Interest Payable, Current $878.00K.
- 2025-09-30: Interest Payable, Current $878.00K.
| Period end | Interest Payable, Current |
|---|---|
| 2026-06-30 | $868.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $849.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $878.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $878.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $868.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $849.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.14M 10-K · filed 2026-03-12 |
| 2024-09-30 | $1.14M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.12M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.11M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.12M 10-K · filed 2025-03-26 |
| 2023-09-30 | $1.10M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.09M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.08M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $1.10M 10-K · filed 2024-03-28 |
| 2022-09-30 | $648.00K 10-Q · filed 2022-11-09 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |